US EditionCheckable Health Urges Rx-to-OTC Reform: 'It's Time to End the Bottleneck'
- On May 14, 2025, Checkable Health, based in Fargo, N.D., urged the FDA to adopt bold regulatory reforms for Rx-to-OTC drug approvals.
- The call follows years of minimal OTC approvals, with fewer than 10 drugs approved from 2019 to 2024, down from 18 in the prior five years.
- Checkable, developing a potential FDA-authorized at-home strep test, highlights that prescription-only status often stems from cost, bureaucracy, and risk aversion, not scientific reasons.
- Founder Patty Post criticized the FDA’s existing procedures for hindering innovation just as the public seeks greater autonomy over their healthcare, calling the situation a widespread issue that results in substantial financial losses and prolongs access to treatment.
- Checkable urges policymakers, healthcare leaders, and entrepreneurs to support a 21st-century regulatory model that speeds OTC access and enables families to take more control over their health.
Insights by Ground AI
Does this summary seem wrong?
21 Articles
21 Articles
All
Left
2
Center
7
Right
Checkable Health Urges Rx-to-OTC Reform: 'It's Time to End the Bottleneck'
FARGO, N.D., May 14, 2025 /PRNewswire/ -- Checkable Health, the company behind what could be the first FDA-authorized at-home strep test, is calling for bold regulatory reform after decades of stagnation in prescription-to-over-the-counter (Rx-to-OTC) innovation. Fueled by recent Trump administration…
Coverage Details
Total News Sources21
Leaning Left2Leaning Right0Center7Last UpdatedBias Distribution78% Center
Bias Distribution
- 78% of the sources are Center
78% Center
L 22%
C 78%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
